tirzepatide consent form pdf free download GL5197E (Mounjaro), Manulife Group Benefits Drug Prior Authorization – Mounjaro (Tirzepatide) (GL5197E) informed consent semaglutide consent form

Unlock your body's full potential with Peptide Therapy a powerful regenerative treatment designed to support optimal wellness, longevity, and aesthetic rejuvenation

Temperature fluctuations matter

Safety Information & Warnings Comprehensive safety and efficacy data will become available upon completion of the phase 3 trials

Retatrutide shows potential for greater efficacy through triple-agonism but awaits Phase 3 results Best For Recommendations# Currently Available Treatment# Recommendation : Tirzepatide Reason : FDA-approved and commercially available as Mounjaro/Zepbound with established dosing protocols and post-market safety data Maximum Weight Loss Potential# Recommendation : Retatrutide Reason : Phase 2 data showed 24.2% weight loss at 48 weeks, exceeding tirzepatide's results, though Phase 3 confirmation is pending Non-Alcoholic Fatty Liver Disease# Recommendation : Retatrutide Reason : Glucagon receptor agonism directly promotes hepatic fat oxidation, showing up to 82% liver fat reduction in trials Type 2 Diabetes Management# Recommendation : Tirzepatide Reason : Proven HbA1c reduction with FDA approval specifically for glycemic control in type 2 diabetes Further Reading# Which Is Better For